Eli Lilly Presents New Exploratory Data From The TOGETHER-PSO Phase 3B Clinical Trial Taltz And Zepbound Compared With Taltz Alone In Adults With Moderate-To-Severe Plaque Psoriasis And Obesity Or Overweight; Data Showed Broader Biomarker Changes With Taltz And Zepbound Vs Taltz Alone

뉴스 본문을 불러오고 있어요.

Eli Lilly Presents New Exploratory Data From The TOGETHER-PSO Phase 3B Clinical Trial Taltz And Zepbound Compared With Taltz Alone In Adults With Moderate-To-Severe Plaque Psoriasis And Obesity Or Overweight; Data Showed Broader Biomarker Changes With Taltz And Zepbound Vs Taltz Alone | 웨이프 WAPE

Eli Lilly Presents New Exploratory Data From The TOGETHER-PSO Phase 3B Clinical Trial Taltz And Zepbound Compared With Taltz Alone In Adults With Moderate-To-Severe Plaque Psoriasis And Obesity Or Overweight; Data Showed Broader Biomarker Changes With Taltz And Zepbound Vs Taltz Alone

기사 요약

관련 종목

댓글 —